BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 22446329)

  • 1. P53 and BCL-2 family proteins PUMA and NOXA define competitive fitness in pluripotent cell competition.
    Valverde-Lopez JA; Li-Bao L; Sierra R; Santos E; Giovinazzo G; Díaz-Díaz C; Torres M
    PLoS Genet; 2024 Mar; 20(3):e1011193. PubMed ID: 38489392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of proapoptotic molecule Noxa in the selective elimination of tumor cells.
    Suzuki S; Nakasato M; Shibue T; Koshima I; Taniguchi T
    Cancer Sci; 2009 Apr; 100(4):759-69. PubMed ID: 19298224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coupled folding and binding of the disordered protein PUMA does not require particular residual structure.
    Rogers JM; Wong CT; Clarke J
    J Am Chem Soc; 2014 Apr; 136(14):5197-200. PubMed ID: 24654952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HEATR1 modulates cell survival in non-small cell lung cancer via activation of the p53/PUMA signaling pathway.
    He S; Ma X; Ye Y; Zhang M; Zhuang J; Song Y; Xia W
    Onco Targets Ther; 2019; 12():4001-4011. PubMed ID: 31190896
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibiting aberrant p53-PUMA feedback loop activation attenuates ischaemia reperfusion-induced neuroapoptosis and neuroinflammation in rats by downregulating caspase 3 and the NF-κB cytokine pathway.
    Li XQ; Yu Q; Chen FS; Tan WF; Zhang ZL; Ma H
    J Neuroinflammation; 2018 Sep; 15(1):250. PubMed ID: 30172256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative identification of deregulated miRNA/TF-mediated gene regulatory loops and networks in prostate cancer.
    Afshar AS; Xu J; Goutsias J
    PLoS One; 2014; 9(6):e100806. PubMed ID: 24968068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p63 transcriptionally regulates the expression of matrix metallopeptidase 13.
    Celardo I; Antonov A; Amelio I; Annicchiarico-Petruzzelli M; Melino G
    Oncotarget; 2014 Mar; 5(5):1279-89. PubMed ID: 24658133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum.
    Ali AY; Farrand L; Kim JY; Byun S; Suh JY; Lee HJ; Tsang BK
    Ann N Y Acad Sci; 2012 Oct; 1271(1):58-67. PubMed ID: 23050965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II regulates activation of Bim via Rb/E2F1 during apoptosis: involvement of interaction between AMPKβ1/2 and Cdk4.
    Kim YC; Day RM
    Am J Physiol Lung Cell Mol Physiol; 2012 Aug; 303(3):L228-38. PubMed ID: 22659879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PUMA, a critical mediator of cell death--one decade on from its discovery.
    Hikisz P; Kiliańska ZM
    Cell Mol Biol Lett; 2012 Dec; 17(4):646-69. PubMed ID: 23001513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bax and BH3-domain-only proteins in p53-mediated apoptosis.
    Wu X; Deng Y
    Front Biosci; 2002 Jan; 7():d151-6. PubMed ID: 11779719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro binding properties of tumor suppressor p53 with PUMA and NOXA.
    Park SY; Jeong MS; Jang SB
    Biochem Biophys Res Commun; 2012 Apr; 420(2):350-6. PubMed ID: 22446329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noxa induces apoptosis in oncogene-expressing cells through catch-and-release mechanism operating between Puma and Mcl-1.
    Nakajima W; Tanaka N
    Biochem Biophys Res Commun; 2011 Oct; 413(4):643-8. PubMed ID: 21945433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Puma(*)Mcl-1 interaction is not sufficient to prevent rapid degradation of Mcl-1.
    Mei Y; Du W; Yang Y; Wu M
    Oncogene; 2005 Nov; 24(48):7224-37. PubMed ID: 16007132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1.
    Day CL; Smits C; Fan FC; Lee EF; Fairlie WD; Hinds MG
    J Mol Biol; 2008 Jul; 380(5):958-71. PubMed ID: 18589438
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.